Cargando…

Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant Strains

As the COVID-19 epidemic progresses with the emergence of different SARS-CoV-2 variants, it is important to know the effectiveness of inactivated SARS-CoV-2 vaccines against the variants. To maximize efficiency, a third boost injection of the high-dose SARS-CoV-2 inactivated vaccine KCONVAC was sele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Chanchan, Su, Jun, Zhang, Chanjuan, Huang, Boya, Mao, Lipeng, Ren, Zhiyao, Bai, Weibin, Li, Huayu, Lei, Guomin, Zheng, Jingshan, Chen, Guobing, Liang, Xiaofeng, Qiu, Congling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503905/ https://www.ncbi.nlm.nih.gov/pubmed/36146822 http://dx.doi.org/10.3390/v14092016

Ejemplares similares

Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination
por: Zhao, Weijun, et al.
Publicado: (2022)

Global analysis of HLA-A2 restricted MAGE-A3 tumor antigen epitopes and corresponding TCRs in non-small cell lung cancer
por: Zhang, Bei, et al.
Publicado: (2023)

Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older adults
por: Xiao, Chanchan, et al.
Publicado: (2023)

Optimization of antigen-specific CD8(+) T cell activation conditions for infectious diseases including COVID-19
por: Xiao, Chanchan, et al.
Publicado: (2021)

CD8(+) T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2
por: Qiu, Congling, et al.
Publicado: (2022)

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom
por: Croda, Julio, et al.
Publicado: (2022)

Epigenetic Application of ATAC-Seq Based on Tn5 Transposase Purification Technology
por: Li, Wangchun, et al.
Publicado: (2022)

Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
por: Ranzani, Otavio T., et al.
Publicado: (2022)

Immunostimulating Effect of Inactivated Parapoxvirus Ovis on the Serological Response to Equine Influenza Booster Vaccination
por: Carnet, Flora, et al.
Publicado: (2022)

Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
por: Yi, Yunyun, et al.
Publicado: (2023)

Phase separation in epigenetics and cancer stem cells
por: Xiao, Chanchan, et al.
Publicado: (2022)

Targeting Rb Mutant Cancers by Inactivating TSC2
por: Searle, Jennifer S., et al.
Publicado: (2010)

Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people
por: Rouco, Santiago Oviedo, et al.
Publicado: (2022)

LncRNA EGOT decreases breast cancer cell viability and migration via inactivation of the Hedgehog pathway
por: Qiu, Shuang, et al.
Publicado: (2020)

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

Chemical excitation and inactivation in photoreceptors of the fly mutants trp and nss
Publicado: (1989)

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021)

Safety and Immunogenicity of Inactivated Bacillus subtilis Spores as a Heterologous Antibody Booster for COVID-19 Vaccines
por: Sung, Johnny Chun-Chau, et al.
Publicado: (2022)

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
por: Tung, Tao-Hsin, et al.
Publicado: (2022)

Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients
por: Zhang, Lei, et al.
Publicado: (2023)

Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
por: Xu, Xingli, et al.
Publicado: (2022)

Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study
por: He, Xiaofeng, et al.
Publicado: (2023)

SARS-CoV-2 variant B.1.1.7 caused HLA-A2(+) CD8(+) T cell epitope mutations for impaired cellular immune response
por: Xiao, Chanchan, et al.
Publicado: (2022)

Field Trial of Primary and Booster Dose of Inactivated Vaccine Against Bovine Respiratory Bacteria in Young Holstein Calves
por: Mori, Kazusa, et al.
Publicado: (2020)

Impact of various vaccine boosters on neutralization against omicron following prime vaccinations with inactivated or adenovirus-vectored vaccine
por: Huang, Qingrui, et al.
Publicado: (2022)

Homologous booster immunization with an inactivated vaccine induced robust antibody response in healthcare workers: A retrospective study
por: Wen, Gui-Ping, et al.
Publicado: (2023)

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
por: Méndez, Constanza, et al.
Publicado: (2023)

Evaluation of PastoCovac plus vaccine as a booster dose on vaccinated individuals with inactivated COVID-19 vaccine
por: Farahmand, Behrokh, et al.
Publicado: (2023)

Inactivated SARS-CoV-2 Vaccine Booster Against Omicron Infection Among Quarantined Close Contacts
por: Liu, Di, et al.
Publicado: (2023)

Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases
por: Liu, Yongmei, et al.
Publicado: (2023)

Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis
por: Zhan, Haoting, et al.
Publicado: (2023)

Antibody response to inactivated COVID‐19 vaccine in patients with type 2 diabetes mellitus after the booster immunization
por: Li, Haolong, et al.
Publicado: (2023)

Immunological risk factors for sepsis-associated delirium and mortality in ICU patients
por: Lei, Wen, et al.
Publicado: (2022)

Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China
por: Miao, Ning, et al.
Publicado: (2020)

Booster
Publicado: (1997)

Mutant p53(R211*) ameliorates inflammatory arthritis in AIA rats via inhibition of TBK1-IRF3 innate immune response
por: Zeng, Yaling, et al.
Publicado: (2023)

Conversion Booster Présentation Interface RF Booster
por: Arruat, M, et al.
Publicado: (1993)

Conversion Booster Présentation layout DSC Booster
por: Arruat, M, et al.
Publicado: (1993)

Serial negative response after standard and third (Booster) dose of COVID-19 inactivated vaccine is associated with low vitamin D levels in patients with solid cancers
por: Ma, Yifei, et al.
Publicado: (2022)

Protective efficacy and immune responses by homologous prime-booster immunizations of a novel inactivated Salmonella Gallinarum vaccine candidate
por: Won, Gayeon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rv66vl9l7e4op4o6h41lun2ss1